Rebecca Shatsky MD

Dr. Rebecca Shatsky is a board-certified medical oncologist who specializes in treating breast cancer. She uses numerous forms of therapy such as chemotherapy, hormone therapy, immunotherapy, and targeted therapy to offer the best treatment options for her patients. She is part of UC San Diego Health's Precision Immunotherapy Clinic, which offers the most promising investigational immunotherapy treatments for many types of cancer.

As a medical oncologist at an academic medical center, Dr. Shatsky teaches medical students, residents, and fellows at UC San Diego School of Medicine. She conducts clinical and translational breast cancer research at Moores Cancer Center at UC San Diego Health. She is the principal investigator of many clinical trials and is part of the national clinical operations leadership for the I-SPY-2 trial. Her translational research focuses on the treatment of triple-negative breast cancer and is funded by multiple sources, including grants from the California Initiative to Advance Precision Medicine and the Breast Cancer Research Foundation. She is a member of the National Comprehensive Cancer Network guideline panel for Genetic/High-Risk Assessment of Breast, Ovarian, and Pancreatic Cancer and the panel for the treatment of Cancer-Associated Pain. Her work has been published in JAMA Oncology, Cancer Cell, and Molecular Cancer Therapeutics, among others.

Dr. Shatsky completed a hematology/oncology fellowship at UC San Diego School of Medicine. She completed her internal medicine residency at UCLA David Geffen School of Medicine and earned her medical degree from the Keck School of Medicine of the University of Southern California. She is board-certified in internal medicine, hematology, and medical oncology. Dr. Shatsky is a member of the American Association for Cancer Research and the American Society of Clinical Oncology.